Deep eutectic solvents (DESs) have recently gained attention due to their tailorable properties and versatile applications in several fields, including green chemistry, pharmaceuticals, and energy storage. Their tunable properties can be enhanced by mixing DESs with cosolvents such as ethanol, acetonitrile, and water. DESs are structurally complex, and molecular modeling techniques, including quantum mechanical calculations and molecular dynamics simulations, play a crucial role in understanding their intricate behavior when mixed with cosolvents. While the most studied cosolvent is water, in some applications, even a small content of water is considered a contaminant, for example, when the processes of interest require dry conditions. Only quite recently have modeling studies begun to focus on DES mixed with cosolvents other than water. This tutorial provides the first comprehensive overview of these studies. It highlights how modern molecular modeling increases our understanding of their structural organization, transport properties, phase behavior, and thermodynamic properties. Additionally, case studies and recent developments in the field are discussed along with the challenges and future directions in molecular modeling of DES in cosolvent mixtures. Overall, this review offers valuable insights into the molecular-level understanding of DES-cosolvent systems and their implications for designing novel solvent mixtures with tailored properties for various applications.
Three new series of indolizines (5a–f, 6a–f and 7a–g), functionalized with bromine or ethyl ester substituents on the pyridine ring, were designed and synthesized as promising anticancer agents. The synthesis of indolizine derivatives was carried out using the 1,3-dipolar cycloaddition of pyridinium N-ylides to ethyl propiolate as a key step. Spectral characterization (using NMR, FT-IR, HRMS and X-ray diffraction) showed that two types of cycloadducts 5a–f and 6a–f were obtained when the ylides generated by the 3-bromopyridinium salts were used as 1,3-dipoles in Huisgen cycloaddition reactions to ethyl propiolate. The anticancer effect of selected compounds was in vitro assessed against the National Cancer Institute (NCI) panel of 60 human tumor cells, at 10 μM concentration, with three compounds (5c, 6c and 7g) showing promising inhibitory activity on the growth of several cell lines including lung, brain, renal cancer and melanoma, as well as a cytotoxic effect against HOP-62 non-small cell lung cells (34% for compound 5c and 15% for compound 7g) and SNB-75 glioblastoma cells (15% for compound 5c and 14% for derivative 7c). Molecular docking revealed favorable binding affinities for 5c, 6c and 7g (–9.22 to –9.88 kcal/mol) at the colchicine-binding site of tubulin with key interactions involving βASN-258, βALA-317, and βLYS-352 residues for 5c, βASN-258 in case of 6c, and αVAL-181 and βLYS-254 for derivative 7g. According to the in silico ADMET analysis, the active compounds are predicted to exhibit good oral bioavailability, promising drug-like qualities and low toxicity risks.
Background: Heteroaromatic iodine-containing compounds have been previously recognized for their broad-spectrum antimicrobial activity. This study aims to systematically investigate their potential repurposing as anticancer agents, with a particular focus on understanding the structural determinants that influence their cytotoxicity and selectivity toward malignant cells. Methods: A series of heteroaromatic iodine-containing derivatives were synthesized and evaluated for anticancer activity. Their cytotoxic effects were measured and compared between cancerous and normal cell lines to determine selectivity. Structural features, including heteroaromatic moieties and substituents, were analyzed to identify correlations with biological activity. Results: Among the tested compounds, derivatives 3e, 3g, and 3l demonstrated significant cytotoxic effects while exhibiting favorable selectivity indices. These findings indicate that these compounds preferentially target malignant cells over normal cells, thereby mitigating the issue of systemic toxicity often associated with traditional chemotherapeutics. The enhanced anticancer activity appears to be influenced by specific structural elements within the heteroaromatic framework. Conclusions: The study highlights the potential of heteroaromatic iodine-containing compounds as promising anticancer candidates. Rational structural modifications within these heterocyclic systems can effectively modulate bioactivity and improve therapeutic selectivity. These results support further development of this compound class for anticancer applications.
DNA, the most iconic molecular architecture, is not only the carrier of genetic information but also a programmable, biocompatible scaffold for nanoscale design. Its structural and physicochemical versatility makes it uniquely suited for self‐assembly, biomedical applications, and the development of dynamic devices and advanced materials. A key determinant of DNA behavior across organizational levels is its interaction with ions, which governs hydration, stability, and compaction from the molecular to the supramolecular scale. Beyond their biological roles, ion‐DNA interactions underpin a variety of technologies: in nanostructure assembly, cations stabilize DNA origami and multihelix constructs; in biosensing, ions enable aptamer folding, DNAzyme catalysis, and metal‐mediated base pairing; in nanomedicine, polyvalent cations drive DNA condensation into polyplexes for gene delivery and stabilize nanorobots for logic‐gated release; and in nanoelectronics and molecular computing, ions enhance DNA conductivity and act as molecular inputs in ion‐responsive logic gates. Ion‐induced condensation, a form of nanoscale confinement driven by electrostatics, remains a central phenomenon, linking biological function to material design. This review emphasizes the technological potential of ion‐driven DNA nanomechanics, integrating experimental evidence with multiscale modeling, and highlights the emerging predictive role of computational tools in guiding the design of next‐generation DNA‐based nanomaterials.